Satish Mehta, MD & CEO of Emcure Pharmaceuticals is having his moment under the sun. Emcure’s subsidiary, Gennova, is working on India’s first indigenously developed mRNA COVID-19 vaccine. Phase-2 and Phase-3 trials are currently underway.
Satish Mehta is a 1975 batch graduate of IIM Ahmedabad, and his father, Raman Lal, was a pharma retailer.
From establishing the company with a bank loan of INR 3 lakh to now operating in over 70 countries and, along the way, attaining the status of a billion-dollar enterprise, Emcure Pharmaceuticals has surely come a long way. The main aim of starting Emcure was to provide affordable and high-quality healthcare to patients to improve their quality of life.
Emcure: The Early Days
Early in the 1980s, Satish Mehta spotted an opportunity to manufacture pharmaceuticals for MNCs and took the plunge and set up Emcure in 1981. About a decade after its inception, Emcure took to manufacturing its products.
With Mehta at the help, Emcure is continuously engaged in developing, manufacturing, and marketing a wide range of pharmaceutical products across the globe.
Progression of Emcure
Over the last 40 years, under the stewardship of the Emcure Pharma CEO, the conglomerate has built a network of 19 subsidiaries, an R&D team comprising 500 scientists, and a global workforce of 11,000 people.
Its lifetime revenues are nearly at Rs 6,000 crore – 44% of which is from the domestic market. Emcure’s turnover as of March 2021 was 500 crore, an increase of 20% in Emcure net worth.
There is no stopping this septuagenarian who never seems to run out of steam. Under the watch of the Emcure Pharma CEO watch, the organization is focussing on R&D and manufacturing capabilities.
In 2016, he was ranked as the 82nd richest Indian on the Forbes Rich List, with a net worth of $1.6 billion.
Namita Thapar is the daughter of Satish Mehta. She joined Emcure as CFO, post her stint at Guidant Corporation, USA. Further, she has an MBA certification from the Fuqua School of Business and is a Chartered Accountant.
you can also check this out Alakh Pandey – Physics Wallah Founder
Namita Thapar currently manages the Indian arm of the business. She has played an active role in propelling Emcure’s domestic growth and consolidating Emcure’s market share.
Namita has also embraced technology initiatives such as data analytics to drive sales. She is passionate about promoting youth entrepreneurship and women’s health in India.
During the pandemic, she launched a YouTube talk show on women’s health named Uncondition Yourself. The program aimed to provide authentic information and break stigmas often associated with women’s health.
Namita also heads Incredible Ventures Ltd, an education company that imparts entrepreneurship knowledge to 11-18-year-olds in Chennai, Bengaluru, Delhi, Pune, Mumbai, and Ahmedabad.
Another feather in her cap is the role of judge on Shark Tank. An entrepreneur may pitch their ideas to the judges who decide whether to invest or pass on the pitch. Just as with most Indian pharma companies the size of Emcure, the core management is family-driven, with key professionals sourced externally. Aside from Satish Mehta, his son, daughter, and son-in-law are with the company, and the Emcure Pharma CEO can rest easy knowing that the firm’s future is in good hands.
